---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-157113"
form_type: "8-K"
ticker: "SNSE"
cik: "0001829802"
company_name: "Sensei Biotherapeutics, Inc."
filed_at: "2025-07-09T23:59:59+00:00"
generated_at: "2026-05-18T08:57:18.350611+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Sensei Biotherapeutics regains Nasdaq minimum bid price compliance

## Summary
- Received Nasdaq letter on July 2, 2025 confirming compliance with Rule 5550(a)(2).
- Closing bid price was at or above $1.00 for 10 consecutive business days (June 17 to July 1, 2025).
- No further action required; delisting risk removed.

## SEC filing metadata
- accession: 0001193125-25-157113
- form_type: 8-K
- ticker: SNSE
- cik: 0001829802
- company_name: Sensei Biotherapeutics, Inc.
- filed_at: 2025-07-09T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1829802/000119312525157113/0001193125-25-157113-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1829802/000119312525157113/d64284d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-157113
- JSON: https://secwatch.observer/filing/0001193125-25-157113.json
- Plain text: https://secwatch.observer/filing/0001193125-25-157113.txt

## Key facts
- Listing & Compliance Notices
  Sensei Biotherapeutics, Inc. received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: compliance regained
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: July 2, 2025, Sensei Biotherapeutics, Inc. (the “Company”) received a letter from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Staff has determined that for 10 consecutive business days, from June 17, 2025 to July 1, 2025, the closing bid price of the Company’s common stock has been at $1.00 per share or greater. Accordingly, the Staff has determined that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2). 2 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registra
  evidence_url: https://www.sec.gov/Archives/edgar/data/1829802/000119312525157113/0001193125-25-157113-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.